Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.41 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.41 |
| ▸ | GMNN | O75496 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | THPO | P40225 | 1/20 | 0.41 |
| ▸ | MTOR | P42345 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CETP | P11597 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | UBE2N | P61088 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11481045 | 1.00 | LMNA (0.48) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL27478764 | 1.00 | LMNA (0.48) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL31532959 | 1.00 | LMNA (0.48) | LMNACYP2D6SPHK1GMNNPOLB | |
| Hydrochloric Acid SCHEMBL3903416 | 0.98 | LMNA (0.47) | LMNACYP2D6SPHK1GMNNPOLB | |
| Ammonia Solution, Strong SCHEMBL6141913 | 0.98 | LMNA (0.47) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL28191238 | 0.98 | LMNA (0.45) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL7717013 | 0.96 | LMNA (0.45) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL28355331 | 0.96 | LMNA (0.45) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL1243043 | 0.96 | LMNA (0.45) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL28359323 | 0.96 | LMNA (0.45) | LMNACYP2D6SPHK1GMNNPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3625 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10945960-B2 | Celecoxib and amlodipine formulation and method of making the same | DEXCEL LTD. (IL) | 2021-03-16 | — | — | US | claimed |
| US-10925835-B2 | Celecoxib and amlodipine formulation and method of making the same | DEXCEL LTD. (IL) | 2021-02-23 | — | — | US | claimed |
| US-20200390713-A1 | CELECOXIB AND AMLODIPINE FORMULATION AND METHOD OF MAKING THE SAME | PURPLE BIOTECH LTD (IL) | 2020-12-17 | — | — | US | claimed |
| CN-111065382-A | Formula of celecoxib and amlodipine and preparation method thereof | 德西尔公司 | 2020-04-24 | — | — | CN | claimed |
| US-20200093128-A1 | ACIDULATED SURFACTANT COMPOSITIONS AND METHODS OF REDUCING MICROBIAL LOAD | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE | 2020-03-26 | — | — | US | claimed |
| US-20190282507-A1 | CELECOXIB AND AMLODIPINE FORMULATION AND METHOD OF MAKING THE SAME | PURPLE BIOTECH LTD (IL) | 2019-09-19 | — | — | US | claimed |
| US-20190008777-A1 | CELECOXIB AND AMLODIPINE FORMULATION AND METHOD OF MAKING THE SAME | PURPLE BIOTECH LTD (IL) | 2019-01-10 | — | — | US | claimed |
| WO-2019008583-A1 | CELECOXIB AND AMLODIPINE FORMULATION AND METHOD OF MAKING THE SAME | DEXCEL LTD. (IL) | 2019-01-10 | — | — | WO | claimed |
| US-20110166225-A1 | ORAL LIQUID COMPOSITIONS OF RHEIN OR DIACEREIN | VERMA HIMANSHU | 2011-07-07 | — | — | US | claimed |
| EP-2280697-A1 | ORAL LIQUID COMPOSITIONS OF RHEIN OR DIACEREIN | Wockhardt Research Centre (IN) | 2011-02-09 | — | — | EP | claimed |
| WO-2009133430-A1 | TOPICAL COMPOSITIONS OF RHEIN OR DIACEREIN | WOCKHARDT RESEARCH CENTRE (IN) | 2009-11-05 | — | — | WO | claimed |
| WO-2009133431-A1 | ORAL LIQUID COMPOSITIONS OF RHEIN OR DIACEREIN | WOCKHARDT RESEARCH CENTRE (IN) | 2009-11-05 | — | — | WO | claimed |
| US-20260146047-A1 | MACROCYCLIC HETEROCYCLE COMPOUNDS AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2026-05-28 | — | — | US | disclosed |
| US-20260147006-A1 | SCREENING METHOD | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2026-05-28 | — | — | US | disclosed |
| US-12637418-B2 | Heterocyclic compounds as antagonist of NMDA | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2026-05-26 | — | — | US | disclosed |
| CN-122094696-A | Adiponectin enhancer, oral composition for adiponectin enhancement, and use of plasmalogen | — | 2026-05-26 | — | — | CN | disclosed |
| EP-0608870-A1 | Quinoline or quinazoline derivatives, their production and use | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1994-08-03 | — | — | EP | disclosed |
| EP-0579221-A1 | Cephem compounds, their production and use | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1994-01-19 | — | — | EP | disclosed |
| EP-0567107-A1 | Quinoline and quinazoline derivatives for treating arthritis | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-10-27 | — | — | EP | disclosed |
| EP-0562599-A1 | Condensed thiadiazole derivative, method of its production, and use thereof | Takeda Chemical Industries, Ltd. (JP) | 1993-09-29 | — | — | EP | disclosed |